XML 27 R9.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Cash flows from operating activities:      
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest $ (105,631) $ (156,594) $ 450,802
Adjustments to reconcile net income to net cash provided by (used in) operating activities:      
Depreciation and amortization 49,604 39,969 25,871
Provision for credit losses 7,147 4,214 1,453
Share-based compensation 45,109 61,140 36,011
Fair value and remeasurement adjustments, non-cash (10,699) 34,871 (7,562)
Non-cash interest and other (9,652) (3,204) (22,322)
Depreciation of rental merchandise 4,070 0 0
Effect of foreign currency on operations (310) 754 127
Loss (income) from equity method investments 181 (3,570) (2,801)
Dividends from equity investments 434 4,038 2,136
Deferred income taxes (40,945) (80,431) 61,770
Impairment of goodwill and tradenames 70,333 0 0
(Gain) loss on sale of business, disposal of fixed assets, and other (9,034) 4,922 (137)
Gain on bargain purchase (15,903) 0 0
Change in fair value of financial instruments and other 0 0 (6,509)
Loss (gain) on extinguishment of debt 5,294 (1,102) 6,131
Gain on equity investment 0 (6,790) (3,544)
De-consolidation of BRPM 150 0 (8,294) 0
Income allocated to and fair value adjustment for mandatorily redeemable noncontrolling interests 1,835 1,119 857
Change in operating assets and liabilities:      
Amounts due to/from clearing brokers (21,903) (69,172) 40,628
Securities and other investments owned 123,196 390,635 (581,785)
Securities borrowed (527,612) (252,361) (1,325,509)
Accounts receivable 26,397 6,599 (715)
Prepaid expenses and other assets 737 (54,273) (3,737)
Accounts payable, accrued payroll and related expenses, accrued expenses and other liabilities (79,848) (141,328) 37,798
Amounts due to/from related parties and partners (1,045) 3,925 (1,415)
Securities sold, not yet purchased 2,704 (22,726) 18,011
Deferred revenue (15,232) 8,966 (3,540)
Securities loaned 525,275 245,346 1,328,875
Net cash provided by operating activities 24,502 6,653 50,894
Cash flows from investing activities:      
Purchases of loans receivable (544,957) (503,146) (738,909)
Repayments of loans receivable 606,716 574,854 172,119
Sale of loans receivable 84,984 0 0
Repayment of loan participations sold 0 0 (15,216)
Acquisition of businesses and minority interest, net of $8,308, $50,733, and $34,942 cash acquired in 2023, 2022, and 2021, respectively (26,240) (261,693) (28,254)
Purchases of property, equipment and intangible assets (7,711) (3,918) (676)
Proceeds from sale of business and other 17,490 2 14
Funds received from trust account of subsidiary 175,763 172,584 0
Investment of subsidiaries initial public offering proceeds into trust account 0 0 (345,000)
Purchases of equity and other investments (4,871) (10,974) (612)
Net cash provided by (used in) investing activities 301,174 (32,291) (956,534)
Cash flows from financing activities:      
Proceeds from revolving line of credit 219,157 64,878 80,000
Repayment of revolving line of credit (303,034) (17,200) 0
Repayment of notes payable and other (13,806) (530) (37,610)
Proceeds from term loan 628,187 324,200 300,000
Repayment of term loan (520,803) (96,228) (20,684)
Proceeds from issuance of senior notes 185 51,601 1,249,083
Redemption of senior notes (58,924) 0 (507,348)
Payment of debt issuance and offering costs (27,993) (8,222) (33,377)
Payment of contingent consideration (1,905) (1,776) (3,714)
ESPP and payment of employment taxes on vesting of restricted stock (7,591) (10,286) (9,620)
Common dividends paid (141,099) (119,454) (347,135)
Preferred dividends paid (8,057) (8,008) (7,457)
Repurchase of common stock (69,479) (6,516) (2,656)
Distribution to noncontrolling interests (6,520) (4,208) (16,542)
Contributions from noncontrolling interests 6,055 21,096 13,680
Redemption of subsidiary temporary equity and distributions (175,763) (172,584) 0
Contributions from noncontrolling interests 0 0 345,000
Proceeds from issuance of common stock 115,000 0 64,713
Proceeds from issuance of preferred stock 467 874 14,712
Net cash (used in) provided by financing activities (365,923) 17,637 1,081,045
(Decrease) increase in cash, cash equivalents and restricted cash (40,247) (8,001) 175,405
Effect of foreign currency on cash, cash equivalents and restricted cash 3,160 (933) (382)
Net (decrease) increase in cash, cash equivalents and restricted cash (37,087) (8,934) 175,023
Cash, cash equivalents and restricted cash, beginning of year 270,926 279,860 104,837
Cash, cash equivalents and restricted cash, end of year 233,839 270,926 279,860
Supplemental disclosures:      
Interest paid 315,309 193,387 138,369
Taxes paid $ 20,121 $ 49,357 $ 88,153